trial

Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy

NCTId NCT00791440
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 34 (actual)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2012-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
34 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2008-11
Primary completion
2012-06
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
Cognitive-Behavior TherapyStandard Psychiatric Treatment

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
David J. Miklowitz, Ph.D.Principal Investigator

Sites

1 total
New York, United States

Facts & assertions

4 sourced
Enrollment
34
Phase
NA
Primary Completion Date
2012-06
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive-Behavior Therapy
drug
Standard Psychiatric Treatment
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Hallucinations
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
investigator
David J. Miklowitz, Ph.D.
person